NS40578/NS/NINDS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2000	1
2003	1
2004	1
2005	2
2006	1
2007	1
2008	1
2009	1
2024	0

1

Contributions of non-human primates to neuroscience research.

Capitanio JP, Emborg ME. Capitanio JP, et al. Lancet. 2008 Mar 29;371(9618):1126-35. doi: 10.1016/S0140-6736(08)60489-4. Lancet. 2008. PMID: 18374844 Review.

2

Evaluation of animal models of Parkinson's disease for neuroprotective strategies.

Emborg ME. Emborg ME. J Neurosci Methods. 2004 Oct 30;139(2):121-43. doi: 10.1016/j.jneumeth.2004.08.004. J Neurosci Methods. 2004. PMID: 15488225 Review.

3

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Déglon N, Aebischer P. Kordower JH, et al. Science. 2000 Oct 27;290(5492):767-73. doi: 10.1126/science.290.5492.767. Science. 2000. PMID: 11052933

4

Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys.

Stephenson DT, Childs MA, Li Q, Carvajal-Gonzalez S, Opsahl A, Tengowski M, Meglasson MD, Merchant K, Emborg ME. Stephenson DT, et al. Cell Transplant. 2007;16(3):229-44. doi: 10.3727/000000007783464704. Cell Transplant. 2007. PMID: 17503735 Free article.

5

Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system.

Kus L, Borys E, Ping Chu Y, Ferguson SM, Blakely RD, Emborg ME, Kordower JH, Levey AI, Mufson EJ. Kus L, et al. J Comp Neurol. 2003 Aug 25;463(3):341-57. doi: 10.1002/cne.10759. J Comp Neurol. 2003. PMID: 12820166

6

The effects of a selective dopamine D2 receptor agonist on behavioral and pathological outcome in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated squirrel monkeys.

Stephenson DT, Meglasson MD, Connell MA, Childs MA, Hajos-Korcsok E, Emborg ME. Stephenson DT, et al. J Pharmacol Exp Ther. 2005 Sep;314(3):1257-66. doi: 10.1124/jpet.105.087379. Epub 2005 Jun 24. J Pharmacol Exp Ther. 2005. PMID: 15980058

7

Basal ganglia lesions after MPTP administration in rhesus monkeys.

Emborg ME, Moirano J, Schafernak KT, Moirano M, Evans M, Konecny T, Roitberg B, Ambarish P, Mangubat E, Ma Y, Eidelberg D, Holden J, Kordower JH, Leestma JE. Emborg ME, et al. Neurobiol Dis. 2006 Aug;23(2):281-9. doi: 10.1016/j.nbd.2006.03.010. Neurobiol Dis. 2006. PMID: 16766201

8

Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration.

Stephenson DT, Li Q, Simmons C, Connell MA, Meglasson MD, Merchant K, Emborg ME. Stephenson DT, et al. Neurobiol Dis. 2005 Nov;20(2):347-59. doi: 10.1016/j.nbd.2005.03.016. Neurobiol Dis. 2005. PMID: 15882945

9

Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF.

Emborg ME, Moirano J, Raschke J, Bondarenko V, Zufferey R, Peng S, Ebert AD, Joers V, Roitberg B, Holden JE, Koprich J, Lipton J, Kordower JH, Aebischer P. Emborg ME, et al. Neurobiol Dis. 2009 Nov;36(2):303-11. doi: 10.1016/j.nbd.2009.07.022. Epub 2009 Aug 4. Neurobiol Dis. 2009. PMID: 19660547 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year